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Exhausted CD4+ T Cells during Malaria Exhibit Reduced
mTORc1 Activity Correlated with Loss of T-bet Expression
Ana Villegas-Mendez,* Garima Khandelwal,† Lucy M. McGowan,*,‡ Rebecca S. Dookie,*
Michael J. Haley,* Charlotte George,x David Sims,x Graham M. Lord,* Linda V. Sinclair,{
Richard G. Jenner,† and Kevin N. Couper*
CD4+ T cell functional inhibition (exhaustion) is a hallmark of malaria and correlates with impaired parasite control and infection
chronicity. However, the mechanisms of CD4+ T cell exhaustion are still poorly understood. In this study, we show that Ag-
experienced (Ag-exp) CD4+ T cell exhaustion during Plasmodium yoelii nonlethal infection occurs alongside the reduction in
mammalian target of rapamycin (mTOR) activity and restriction in CD4+ T cell glycolytic capacity. We demonstrate that the loss
of glycolytic metabolism and mTOR activity within the exhausted Ag-expCD4+ T cell population during infection coincides with
reduction in T-bet expression. T-bet was found to directly bind to and control the transcription of various mTOR and metabolism-
related genes within effector CD4+ T cells. Consistent with this, Ag-expTh1 cells exhibited significantly higher and sustained
mTOR activity than effector T-bet– (non-Th1) Ag-expT cells throughout the course of malaria. We identified mTOR to be
redundant for sustaining T-bet expression in activated Th1 cells, whereas mTOR was necessary but not sufficient for maintaining
IFN-g production by Th1 cells. Immunotherapy targeting PD-1, CTLA-4, and IL-27 blocked CD4+ T cell exhaustion during
malaria infection and was associated with elevated T-bet expression and a concomitant increased CD4+ T cell glycolytic meta-
bolism. Collectively, our data suggest that mTOR activity is linked to T-bet in Ag-expCD4+ T cells but that reduction in mTOR
activity may not directly underpin Ag-expTh1 cell loss and exhaustion during malaria infection. These data have implications for
therapeutic reactivation of exhausted CD4+ T cells during malaria infection and other chronic conditions. The Journal of
Immunology, 2020, 205: 000–000.
M
alaria, caused by infection with Plasmodium spp. par-
asites, continues to be a major health and economic
burden in many parts of the world (1, 2). CD4+ T cells
orchestrate protective immunity to blood-stage malaria by acti-
vating macrophages to kill the parasite and helping B cells pro-
duce Ab (3–5). Studies of human malaria and experimental
murine models of infection have, however, shown that effector
CD4+ T cells become hyporesponsive (or exhausted) during the
course of malaria, with loss of proliferative capacity, repressed
cytokine production, and reduced ability to help macrophages and
B cells (3, 5, 6). The loss of effector CD4+ T cell function during
malaria infection directly correlates with impaired parasite control
and the establishment of chronic malarial infections (3).
It is increasingly understood that T cell activation, differentia-
tion, and effector function are all intrinsically governed by cellular
metabolic programs (7–10). TCR signals, IL-2, and costimulatory
pathways converge to activate mammalian target of rapamycin
complex 1 (mTORc1), which is a critical metabolic hub that
promotes anabolic metabolic programs, such as glycolysis and
amino acid metabolism, necessary for T cell proliferation and de
novo macromolecule generation (7–10). Thus, mTORc1 is non-
redundantly required for generation of effector T cell subsets,
including Th1 cells, Th17 cells, and CTLs, during various dif-
ferent inflammatory conditions and infections and for controlling
effector T cell functions, such as IFN-g and granzyme B pro-
duction (8, 9, 11). Notably, there is evidence that mTORc1 and
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anabolic metabolic programs are repressed in tumor-infiltrating
effector T cells and in exhausted effector T cells during chronic
viral infections (12–14). The importance of mTOR in T cell acti-
vation during malaria infection and whether alterations in metabolic
programming also underlie CD4+ T cell functional exhaustion
during malaria infection has not been examined.
Various coinhibitory pathways and regulatory cytokines have
been shown to play roles in inhibiting T cell proliferation and
effector function during malaria infection (15–17). Abrogation of
cell surface regulatory receptor activities, including blockade of
PD1, CTLA-4, LAG-3, Tim3, and BTLA, have been shown to
improve CD4+ T cell and/or CD8+ T cell responses and enhance
parasite control during different murine Plasmodium spp. infec-
tions (15, 18–22). Moreover, PD-1, CTLA-4, LAG-3, and Tim-3
have been suggested to contribute to T cell immunosuppression
during human Plasmodium falciparum infection (15, 21–24). We
have also previously shown that IL-27 plays a nonredundant
dominant role in limiting the magnitude of Th1 cell responses
during murine malaria (25, 26). Consequently, targeting regulatory
pathways has been proposed as a therapeutic strategy during
malaria infection (15, 27). Although we still have limited mecha-
nistic understanding of how regulatory pathways suppress effector
T cell responses during malaria infection, PD-1 and CTLA-4 have
been shown to inhibit mTOR activity in T cells during in vitro
stimulation experiments (28, 29).
In this study, we have examined whether CD4+ T cell exhaus-
tion during malaria infection is orchestrated through changes in
mTOR-dependent cellular metabolism. We demonstrate that
lowered mTOR activity in effector CD4+ T cells during the course
of Plasmodium yoelii nonlethal (PyNL) infection correlates with
the temporal loss of T-bet expression. T-bet directly bound to
and activated the expression of various mTOR-activating and
metabolic genes, and Th1 cells exhibited high levels of sustained
mTOR activity compared with T-bet–deficient effector CD4+
T cells throughout the course of infection. Notably, immunother-
apy to block T cell exhaustion during malaria infection raised
CD4+ T cell glycolytic metabolism associated with an increase
in T-bet expression. Our results define T-bet as a potentially
important controller of mTORc1 activity in effector T cells and
have implications for understanding the mechanisms of Th1 cell
exhaustion and functional repression during malaria infection
and other chronic infections.
Materials and Methods
Ethics
Animal work was approved by the University of Manchester Animal
Procedures and Ethics Committee and was performed in accordance with
the U.K. Home Office Animals (Scientific Procedures) Act 1986 (project
licenses 70/7293 and P8829D3B4).
Mice and parasites
C57BL/6 mice were purchased from Charles River Laboratories, Margate,
U.K. and were maintained at the University of Manchester. IL-27R–
deficient [WSX-12/2 mice (30)] were bred and maintained at the Uni-
versity of Manchester. mTORflox/flox mice (31) obtained from The Jackson
Laboratory, were crossed with CD4-Cre mice (32) to generate T cell–
specific mTOR-deficient mice (CD4-Cre+/2 mTORflox/flox) and littermate
control mice (CD4-Cre2/2 mTORflox/flox). All mice were housed in indi-
vidually ventilated cages (transgenic mice and controls were cohoused
within cages). Sex-matched 6–10-wk-old age-matched mice were used in
separate experiments.
Cryopreserved PyNL or Plasmodium berghei NK65-GFP parasites (33)
were thawed and passaged once through C57BL/6 mice. Experimental
mice were subsequently infected i.v. with 1 3 104 parasitized RBCs
(pRBCs) by injection into the tail vein. In some experiments, randomized
mice were injected i.p. with 250 mg of anti-mouse PD-L1 (clone 10F.9G2)
and anti-mouse CTLA-4 (clone UC10-4F10-11) every 2 d, from day 3
postinfection. All Abs were from Bio X Cell (West Lebanon, NH). Pe-
ripheral parasite burdens were monitored every second day of infection by
microscopic examination of Giemsa-stained thin blood smears.
Flow cytometry
Spleens were collected from naive and malaria-infected mice. Single-cell
suspensions were prepared by homogenizing tissue through a 70-mm cell
strainer (BD Biosciences). RBCs were lysed (RBC Lysing Buffer; BD
Biosciences), and samples were washed in FACS buffer (HBSS with 2%
FCS) and resuspended in RPMI 1640 supplemented with 10% FCS. Live/
dead cell counting and absolute cell numbers were calculated by trypan
blue exclusion (Sigma-Aldrich) using a C-Chip (NanoEntek, Pleasanton,
CA). For all staining protocols, 43 106 cells per sample were washed with
PBS and stained with LIVE/DEAD Fixable Blue Dead Cell Stain Kit for
UVexcitation (Life Technologies). Samples were then surface stained with
anti-mouse Abs against CD4 (RM4-5), CD8 (53-6.7), ICOS (C398.4A), KLRG-
1 (2F1), CD25 (PC61), CD98 (4F2), CD71 (R17217), PD-1 (29F.1A12), CD11a
(M17/4), CD49d (R1-2), CD44 (Im7), CD62L (MEL-14), and CXCR5
(1.138D7). For intracellular staining, surface-stained cells were washed
in FACS buffer and permeabilized with Foxp3 fixation/permeabilization
buffers (eBioscience, Thermo Fisher Scientific) for 30 min. The cells were
then stained with anti-mouse Abs against Ki-67 (SolA15), T-bet (4B10),
CTLA-4 (UC10-4B9), GATA3 (TWAJ), Foxp3 (FJK-165), Bcl-6 (7D1),
Glut-1 (FAB1418R), and c-Myc (D84C12).
For intracellular staining of phosphorylated proteins, an alternative
protocol was used (as described in Ref. 25). Briefly, splenocytes were kept
on ice and immediately fixed for 15 min on ice by addition of an equal
volume of 4% paraformaldehyde. Cells were permeabilized with 90% ice-
cold methanol at 220˚C overnight and then stained for CD4, CD49d,
CD11a, T-bet, pS6 (Ser235, Ser236) (cupk43k), p4EBP1 (Thr36, Thr45)
(V3NTY24), and pAKT (Ser473) (700392).
Intracellular IFN-g and TNF production was assessed ex vivo on whole
splenocytes. For this, 1 3 106 live cells were incubated in RPMI 1640
medium supplemented with 10% FCS, 200 ng/ml PMA (Sigma-Aldrich)
and 1 mg/ml ionomycin (Sigma-Aldrich) in the presence of brefeldin A
(1∶1000; eBioscience, Thermo Fisher Scientific) for 4 h at 37˚C, 5% CO2.
Samples were surfaced stained first, followed by intracellular staining as
described above, using anti-mouse Abs against IFN-g (XMG1.2) and TNF
(MP6-XT22) for 30 min. All Abs were from eBioscience Thermo Fisher
Scientific, BioLegend or Novus Biologicals. Fluorescence-minus-one con-
trols were performed to validate Ab staining. Data acquisition was performed
using a Fortessa instrument (BD Systems), and analysis was performed using
FlowJo software (Tree Star, Ashland, OR).
Quantification of cytokine secretion by CD4+ T cells
Splenic CD4+ T cells from naive and malaria-infected mice (day 5, 9, and
15 of infection) were positively selected by magnetic cell sorting as de-
scribed above. A total of 2 3 105 cells were incubated in RPMI 1640
medium supplemented with 10% FCS, 200 ng/ml PMA (Sigma-Aldrich)
and 1 mg/ml ionomycin (Sigma-Aldrich) on 96-well plates for 4 h at 37˚C,
5% CO2. Cell supernatants were stored at 280˚C until further use. The
concentrations of IL-2, IFN-g, TNF, and IL-10 in the supernatants were
measured by a Cytometric Bead Array Mouse Th1/Th2/Th17 Cytokine Kit
(BD Biosciences), following the manufacturer’s instructions.
Inhibition of mTOR activity on in vitro–activated Th1 cells
Splenic CD4+ T cells from naive mice were positively selected by mag-
netic cell sorting using anti-CD4 microbeads (Miltenyi Biotech), according
to the manufacturer’s guidelines. Cells were seeded at a density of 1 3 106
cells in a 24-well plate, and activated with 2 mg/ml anti-CD3 (BD Bio-
sciences) and 2 mg/ml anti-CD28 (eBioscience). Cells were grown for
3 d under Th1-polarizing conditions (10 ng/ml rIL-12 [R&D Systems])
10 mg/ml anti–IL-4 (clone 11B11; eBioscience, Thermo Fisher Sci-
entific), split, and further grown until day 4 or 5 under Th1-polarizing
conditions and 5 ng/ml rIL-2 (R&D systems). mTOR signaling was
blocked by addition of 250 nM Torin (Tocris Bioscience, Bio-Techne)
or PBS vehicle control either from day 0 or 3. mTOR signaling, T-bet
expression, and IFN-g production in CD4+ CD44+ T cells was measured by
flow cytometry, as described above.
Inhibition of mTOR activity on infection-derived splenocytes
Splenocytes from naive and malaria-infected mice were prepared as de-
scribed above and incubated for 40 min at 37˚C, 5% CO2 at a density of
6 3 106 cells on 48-well plate with or without anti-CD3/anti-CD28, as
described above. mTOR activity was inhibited by addition of 250 nM
Torin. mTOR signaling and T-bet expression in CD4+ CD49d+ CD11a+
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T cells was measured by flow cytometry, following the intracellular
phosphorylation protocol described above.
Extracellular flux metabolic assay
Splenic CD4+ T cells from naive and malaria-infected mice (day 5 and 15
of infection) were positively selected by magnetic cell sorting as described
above. Cells were plated at a density of 200,000 cells per well on
Cell-Tak–coated XFe96 Cell Culture Microplates (Agilent Technologies)
in assay media (nonbuffered RPMI 1640 containing 10 mM glucose,
2 mM L-glutamine, and 1 mM sodium pyruvate). Oxygen consumption
rates (OCR) and extracellular acidification rates (ECAR) were mea-
sured in assay media under basal conditions and in response to mi-
tochondrial inhibitors, 2 mM oligomycin plus 2 mM carbonyl cyanide
p-trifluoromethoxyphenylhydrazone and 100 nM rotenone plus 1 mM anti-
mycin A (Sigma-Aldrich), and the glycolysis inhibitor 2-deoxy-D-glucose
(50 mM) on the Seahorse XF96 Extracellular Flux Analyzer (Agilent
Technologies).
Image stream
In vitro–activated CD4+ T cells were surface stained for 25 min at 4˚C with
CD4 (RM4-5). For intracellular staining, cells were incubated with Foxp3
fixation/permeabilization buffer for 30 min at 4˚C. Cells were then stained
with T -bet (4B10) for 30 min at 4˚C, before resuspending in PBS containing
DAPI. Dead cells were excluded using fixable viability dye (Invitrogen).
Cells were analyzed with an ImageStream X Mark II (Amnis), and data were
analyzed with IDEAS (Amnis).
Bioinformatics analysis
RNA-sequencing (RNA-seq) data for wild-type (WT) and T-bet knockout
(KO) Th1 cells were downloaded for three different studies from the Gene
Expression Omnibus (Ref. 34, GSE40463; Ref. 35, GSE38808; Ref. 36,
GSE48138). The data were aligned to the mm10 genome assembly with a
splice junctions file generated using Ensembl 81 using STAR (37). RNA
abundance was quantified using featureCounts (38) in R, using the
Ensembl 97 gene transfer format file. Differential expression analysis was
performed between WT and T-bet KO groups with DESeq2 (39) in R
(R Core Team. 2017. R: A language and environment for statistical
computing. R Foundation for Statistical Computing, Vienna, Austria.
Available at https://www.R-project.org/). Significantly differentially
expressed genes (adjusted p value ,0.01) were sorted on the basis of log2
fold change values plotted as a heatmap using pheatmap in R (R. Kolde.
2019. pheatmap: Pretty Heatmaps. R package version 1.0.12. Available at
https://CRAN.R-project.org/package=pheatmap). Gene enrichment analy-
sis was performed on the significantly upregulated genes using the gPro-
fileR package (40) in R. Sets of genes associated with enhancers and
superenhancers were taken from Hertweck et al. (41), and gene enrichment
analysis was performed with the gProfileR package in R. T-bet chromatin
immunoprecipitation sequencing data were taken from GSE62486 (41) and
realigned to Mus musculus 10 with bowtie2 (–very-sensitive parameters)
(42). Replicate RNA-seq bam files were merged, and bigWig files were
generated with the bamCoverage function (–normalizeUsing RPGC–
binSize 10 parameter) from deepTools (43) for visualization in the UCSC
Genome Browser.
Statistical analysis
Except for RNA-seq data, all statistical analyses were performed using
GraphPad Prism (GraphPad Software). Data were checked for normality
using the Shapiro–Wilk test. For normally distributed data, statistical
significance for two-group comparisons was determined using the t test;
nonparametric data were analyzed using the Mann–Whitney U test. Statis-
tical significance on three or more group comparisons was determined using
one-way or two-way ANOVAwith Tukey post hoc analysis (parametric data)
or the Kruskal–Wallis test with a Dunn post hoc test (nonparametric data).
Results were considered significantly different when the p value was ,0.05.
Results
mTOR is required for development of Ag-experienced CD4+
T cell responses during PyNL infection
The specific requirement of T cell–intrinsic mTOR expression and
activation for generation of T cell responses during malaria infec-
tion is unknown. Thus, to investigate this we infected T cell–specific
mTORD/D mice (CD4-cre+/2 X mTORflox/flox) with PyNL. Phos-
phorylation of S6 and 4EBP1 (associated with mTORc1 activity)
and AKT473 (associated with mTORc2 activity) was observed on
day 5 of infection in CD4+ T cells from WT littermates but
not from mTORD/D animals, indicating that the mTORc1 and
mTORc2 pathways were activated in WT CD4+ T cells during
the initiation of the immune response during malaria infection
(Fig. 1A). mTOR-deficient CD4+ T cells failed to upregulate Ki67
expression during PyNL infection, indicative of a failure to prolif-
erate (Fig. 1B). Consequently, the number of splenic Ag-experienced
(Ag-exp) CD11a+CD49d+ CD4+ T cells, which contain parasite-
specific CD4+ T cell populations (22, 44), was significantly attenu-
ated in mice with a CD4 T cell–specific mTOR deficiency on days
5 and 15 of infection (Fig. 1C). The Ag-expCD4+ T cells that
did form in T cell–specific mTORD/D mice also showed defec-
tive signs of activation, including reduced expression of ICOS,
CXCR3, and the coinhibitory molecules PD-1 and CTLA-4 (re-
sults not shown). Combined, this led to the abrogated expansion of
effector Th1 (T-bet+) and T follicular helper (Tfh; CXCR5+PD-1+)
subsets in T cell mTORD/D mice during the course of PyNL in-
fection (Fig. 1D, 1E). Interestingly, although the proportions of
Foxp3+ regulatory T cells were increased (Fig. 1F), there was still
a significant reduction in the overall number of Foxp3+ regulatory
T cells in T cell–specific mTORD/D mice at the later stage of in-
fection (Fig. 1G). Consistent with these data, parasite control was
reduced in T cell–specific mTORD/D mice at the later stages of
PyNL infection (Fig. 1H). Overall, these data highlight the critical
requirement for mTOR in CD4+ T cells for the development of an
effector Ag-expCD4+ T cell response during PyNL infection.
mTOR activation is not sustained in Ag-expCD4+ T cells,
which become functionally impaired during the course of
PyNL infection
Having verified the importance of T cell–intrinsic mTOR activity
in development of effector T cell responses during malaria in-
fection, we examined the dynamics of mTOR activity during the
onset of T cell exhaustion. Ag-expCD4+ T cells rapidly became
exhausted during PyNL infection in WT mice. On day 5 of infec-
tion, Ag-expCD4+ T cells were highly proliferative and exhibited a
proinflammatory phenotype, as defined by production of IFN-g and
expression of Ki67, ICOS, and CD25 (Fig. 2A, 2B). However, by
day 9 postinfection, Ag-expCD4+ T cells had a reduced capacity to
produce IFN-g compared with Ag-expCD4+ T cells on day 5 of
infection and exhibited low expression of Ki67, indicating minimal
active proliferation (Fig. 2A, 2B). Ag-expCD4+ T cell effector
function continued to deteriorate between days 9 and 15 of in-
fection, with cells on day 15 of infection, expressing low levels
of Ki67, ICOS, and CD25 and producing very low levels of TNF,
IFN-g, IL-2, and IL-10 (Fig. 2A, 2B, Supplemental Fig. 1A).
To assess mTOR activity in the Ag-expCD4+ T cells as they
became functionally exhausted during the course of PyNL infection,
we examined the temporal expression of pS6, p4EBP1, pAKT473,
and the metabolic regulator c-Myc. On day 5 of infection, when
Ag-expCD4+ T cells exhibited strong effector function, the cells
expressed high levels of pS6, p4EBP1, pAKT473 and c-Myc
(Fig. 2C, 2D). However, the expression of these molecules was not
maintained, and in parallel with the loss of effector function,
Ag-expCD4+ T cells on day 15 of infection exhibited significantly
reduced activation of pS6, p4EBP1, pAKT473, and c-Myc com-
pared with Ag-expCD4+ T cells on day 5 of infection (Fig. 2C,
2D). Importantly, detection of p4EBP1 in Ag-expCD4+ T cells on
days 5 and 15 of infection was almost completely blocked (similar
to background staining within naive T cells) by treatment with the
pan mTOR inhibitor Torin (Supplemental Fig. 1B). In contrast, the
expression of pS6 was only reduced by ∼30% in Ag-expCD4+
T cells on day 5 of infection following treatment with Torin, and
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expression was not modified in Ag-expCD4+ T cells on day 15
of infection (Supplemental Fig. 1C). Thus, although pS6 and
p4EBP1 are both frequently discussed as measures of mTORc1
activation and induction of anabolic metabolic programs (7–10),
only p4EBP1 expression was Torin sensitive (and thus presumed
to be mTOR dependent) in Ag-expCD4+ T cells during malaria
infection. mTOR-independent phosphorylation of S6235/236 in
T cells has previously been shown (45). Ag-expCD4+ T cells on
day 15 of infection also showed a defect in capacity to engage the
mTORc1 pathway following strong in vitro TCR stimulation
compared with Ag-expCD4+ T cells obtained from day 5 of infec-
tion, as determined by p4EBP1 expression (Supplemental Fig. 1D).
Combined, these data demonstrate that CD4+ T cell functional
exhaustion, as defined by lowered proliferation and reduced IFN-g
production, occurs alongside the apparent loss of mTORc1 activity
during malaria infection.
Exhausted CD4+ T cells have impaired nutrient uptake and
exhibit loss of glycolytic cellular metabolism during
malaria infection
It is thought that mTOR has a major role in the integration of
nutrient uptake and cellular metabolic pathways, including gly-
colysis (7–10). Consequently, we examined whether the reduc-
tion in mTORc1 activity in Ag-expCD4+ T cells during PyNL
infection translated to differences in glycolytic metabolism.
On day 15 of infection, Ag-expCD4+ T cells expressed lower
levels of Glut-1 (a glucose transporter), CD98 (a component of
the Slc7a5 heterodimeric large neutral amino acid transporter),
and CD71 (a transferrin receptor) than Ag-expCD4+ T cells from
day 5 of infection (Fig. 3A, 3B). CD4+ T cells on day 15 of in-
fection also exhibited a significantly lower basal and maximal
ECAR (a measure of glycolysis) than CD4+ T cells from day 5 of
infection, indicating that CD4+ T cells lost glycolytic capacity
concurrent with onset of functional exhaustion during infection
(Fig. 3C–E). Indeed, CD4+ T cells from day 15 of infection
exhibited ECAR that was only modestly increased compared with
resting CD4+ T cells from naive mice (Fig. 3C–E). However, in
contrast with the dynamic alterations in ECAR, CD4+ T cells
exhibited relatively stable basal and maximal OCR (a measure
of mitochondrial respiration) during the course of infection, in-
dicating that the CD4+ T cells maintained equivalent levels of
oxidative phosphorylation during the course of PyNL infection
(Fig. 3F–H). Thus, when analyses were combined, CD4+ T cells
from day 15 of infection had a significantly diminished energetic
profile and an increased OCR/ECAR metabolic ratio than cells
from day 5 of infection (Fig. 3I, 3J).
Reduction in glycolytic metabolism of Ag-expCD4+ T cells
during malaria infection correlates with loss of T-bet
expression and the collapse of the metabolically active
Th1 subset
The above data are in agreement with recent studies suggesting that
T cell exhaustion is associated with loss of mTOR activity and
metabolic dysfunction (12, 46, 47). We consequently examined the
FIGURE 1. mTOR is required for development of an effector CD4+ T cell response during malaria infection. T cell–specific mTOR KO and littermate
(WT) mice were infected i.v. with 13 104 PyNL pRBCs. (A) Representative histograms showing the levels of pS6, p4EBP1, and pAKT473 in splenic CD4+
T cells on day 5 postinfection compared with naive CD4+ T cells from uninfected mice. (B) Representative histogram showing the level of Ki67 in splenic
CD4+ T cells on day 5 postinfection, compared with naive CD4+ T cells from uninfected mice. (C) The numbers of Ag-expCD4+ T cells (CD11a+CD49d+)
in the spleen of T cell–specific mTOR KO and WT mice on days 5 and 15 postinfection. (D and E) The numbers of splenic (D) Ag-expCD4+ T-bet+ cells and
(E) Ag-expCD4+ Tfh (PD-1+CXCR5+) cells on days 5 and 15 postinfection. (F and G) The (F) proportions and (G) numbers of CD4+ Foxp3+ cells on days 5
and 15 postinfection. (H) Peripheral parasitemia as measured by Giemsa thin blood smear. Results are mean6 SEM of the group (n = 3–4) from one of two
or three independent experiments. *p , 0.05 between defined groups by t test or two-way ANOVA with Tukey post hoc test.
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molecular basis for the reduction in mTOR activity in exhausted
T cells during malaria infection. We observed a dramatic reduc-
tion in T-bet expression by Ag-expCD4+ T cells and a reduced
proportion of Ag-expCD4+ T cells expressing T-bet (Th1 cells) as
PyNL infection progressed and T cell exhaustion was established
(Fig. 4A–C). T-bet expression was directly correlated with
p4EBP1 expression in Ag-expCD4+ T cells during infection
(Fig. 4D). In agreement, Ag-expT-bet+ Th1 cells exhibited higher
and sustained mTOR activity, as indicated by p4EBP1 expression
[the expression of which, above baseline levels observed in naive
T cells, was Torin sensitive (Supplemental Fig. 1E)] and an elevated
metabolic signature (c-Myc and pS6) compared with Ag-expT-bet2
non-Th1 cells on both days 5 and 15 of infection (Fig. 4E, 4F,
Supplemental Fig. 2A). Although Ag-expT-bet2 T cells were a
heterogeneous population, they were predominantly CD44+CD62L2
Foxp32 Gata-32, non-Tfh (CXCR52PD-12) effector T cells
(Supplemental Fig. 2B, 2C). Exhausted CD4+ T cells have previ-
ously been shown to exhibit an equivalent nonpolarized phenotype
during lymphocytic choriomeningitis virus infection (48, 49).
These data raised the question whether the temporal reduction of
mTORc1 activity (as inferred by lower p4EBP1 expression) and
glycolytic metabolism in the exhausted Ag-expCD4+ T cell pop-
ulation during malaria infection was a consequence of the loss of
T-bet. To test this, we performed a meta-analysis of published
RNA-seq data (34–36) from T-bet–null versus WT CD4+ T cells
polarized under Th1 conditions in vitro to identify genes down-
regulated in effector CD4+ T cells upon loss of T-bet expression
(Supplemental Fig. 3A). This revealed enrichment of genes with
functions in Gene Ontology categories. such as regulation of im-
mune effector process, and Kyoto Encyclopedia of Genes and
Genomes (KEGG) pathways, such as Th1 and Th2 cell differen-
tiation, as might be expected, but also downregulation of genes in
the mTOR signaling pathway and the PI3K–AKT and MAPK
signaling pathways that regulate mTOR function (Fig. 5A). To
address whether T-bet directly regulated these genes, we identified
the enhancers and superenhancers bound by T-bet in Th1 cells. As
we have found previously (41), genes associated with T-bet–bound
superenhancers had functions related to IFN-g production,
FIGURE 2. mTOR activity declines in Ag-expCD4+ T cells concomitant with loss of T cell functionality during PyNL infection. C57BL/6 mice
were infected i.v. with 1 3 104 PyNL pRBCs. (A) Representative histograms and (B) calculated mean fluorescence intensity (MFI) (mean of the group) for
IFN-g, Ki67, ICOS, and CD25 in splenic Ag-expCD4+ T cells during the course of infection compared with naive CD4+ T cells from uninfected mice
(day 0). (C) Representative histograms and (D) calculated MFI (mean of the group) for pS6, p4EBP, pAKT473, and c-Myc in splenic Ag-expCD4+ T cells
during the course of infection compared with naive CD4+ T cells from uninfected mice (day 0). Results are the mean 6 SEM of the group (n = 4) and are
from one of three or four independent experiments. *p , 0.05 between defined groups by one-way ANOVA with Tukey post hoc test.
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inflammatory response, and chemotaxis (Fig. 5B). In contrast,
genes associated with T-bet–bound typical enhancers were
enriched in functions relating to metabolism and PI3K–AKT
MAPK, AMPK, and insulin receptor signaling (Fig. 5B). Thus,
T-bet regulates metabolic functions through a distinct set of ele-
ments to those used to regulate the inflammatory response. Genes
bound and activated by T-bet included Sgk1, Nedd4, and Pik3ap1
(Fig. 5C), which function in pathways that positively regulate
mTOR activity (50–53). These results suggest that T-bet may
control mTOR activity in effector T cells and that loss of T-bet
may, in part, contribute to loss of mTOR activity and glycolytic
metabolism within T cells during establishment of cellular
exhaustion.
mTOR does not sustain T-bet expression and is necessary but
not sufficient for IFN-g production in established Th1
effector cells
Although the above results suggested that T-bet may positively
effect mTOR activity, it has also previously been shown that mTOR
promotes T-bet activity in T cells (54–56), suggesting that T-bet
and mTOR may exist in an interlinked pathway to coordinate
lineage commitment and cellular metabolic programming within
effector T cells. Consequently, to examine whether a reduction in
mTOR activity caused lowered T-bet expression in exhausted Ag-
expCD4+ T cells during malaria infection, we treated Ag-expCD4+
T cells obtained from mice on days 5 and 15 of PyNL infection
with Torin. Interestingly, Torin failed to modify expression of
T-bet in Ag-expCD4+ T cells obtained on either day of infection
(Fig. 6A). Moreover, treatment of in vitro–generated Th1 cells
with Torin on day 3 of activation did not modify T-bet expression
or alter T-bet nuclear translocation when the Th1 cells were ex-
amined on days 4 or 5 of stimulation (Fig. 6B, Supplemental Fig.
3B). This was evident, even though Torin inhibited p4EBP1 ex-
pression (to the background staining level observed in unstimu-
lated naive T cells), showing it was likely effective at inhibiting
mTORC1 in Th1 cells (Fig. 6C). In contrast, administration of
Torin at the initiation of in vitro CD4+ T cell activation and Th1
differentiation completely abrogated T-bet expression (Fig. 6D).
Thus, these data suggest that, although mTOR is necessary for
induction of T-bet during T cell priming, it is not required for
sustained T-bet expression in activated Th1 cells during infection.
As such, the reduction in T-bet expression in exhausted Ag-
expCD4+ T cells during malaria infection may not be directly due
to the inhibition of mTOR activity.
In contrast to the effects on T-bet, we observed that Torin ad-
ministration inhibited IFN-g production by CD4+ T cells during
in vitro priming as well as by in vitro–activated and fully differ-
entiated Th1 cells (Fig. 6E, 6F). This shows that mTOR activity
is necessary for IFN-g production by Th1 cells. Nevertheless,
Ag-expT-bet+ Th1 cells on day 15 of infection exhibited reduced
proliferation (Ki67+), function (IFN-g+), and activation (ICOS+)
compared with Ag-expT-bet+ Th1 cells on day 5 of infection
(Fig. 6G). This was despite the Ag-expT-bet+ Th1 cells from days
5 and 15 of PyNL infection expressing equivalent levels of
p4EBP1, pS6, pAKT473, and c-Myc (Fig. 6H). Consequently,
these results imply that mTOR activity is not sufficient to maintain
Th1 cell effector function during PyNL infection, with Th1 cell
function (as defined by Ki67 expression and IFN-g production)
FIGURE 3. CD4+ T cells exhibit temporal loss in glycolytic capacity during the course of PyNL infection. C57BL/6 mice were infected i.v. with 13 104
PyNL pRBCs. (A) Representative histograms and (B) calculated mean fluorescence intensity (MFI) (mean of the group) for Glut1, CD98, and CD71 in
splenic Ag-expCD4+ T cells during the course of infection, compared with naive CD4+ T cells from uninfected mice (day 0). (C–E) Seahorse analysis using
modified mitochondrial stress test showing level of (C) ECAR and calculated (D) basal ECAR and (E) maximum glycolytic capacity of splenic CD4+ T cells
from infected mice and naive mice. (F–H) Seahorse analysis showing level of (F) OCR and calculated (G) basal OCR and (H) maximal respiration of splenic
CD4+ T cells from infected mice and naive mice. (I) Metabolic phenotype analysis and (J) the basal OCR:ECAR ratio of CD4+ T cells from naive and
infected mice. Results are the mean6 SEM of the group (n = 4) and are from one of two or three independent experiments. *p, 0.05 by one-way ANOVA
with Tukey post hoc test.
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restrained during malaria infection in the absence of alterations in
mTOR activity and nutrient transporter expression.
PD-1 and CTLA-4 control of CD4+ T cell glycolytic
metabolism is associated with control of T-bet expression, but
they do not influence mTOR activity within mature Th1 cells
during PyNL infection
As mTOR did not appear to directly control T-bet expression in
Ag-expCD4+ T cells during malaria infection, we questioned
which other pathways may influence T-bet to affect Ag-expCD4+
T cell glycolytic metabolism and cellular exhaustion during PyNL
infection. The regulatory pathways PD-1 and CTLA-4 have been
shown to suppress T cell function during malaria infection and to
influence cellular metabolism in other models (15, 18–20, 23, 28,
29). As expected, the expression of PD-1 and CTLA-4 was up-
regulated on Ag-expCD4+ T cells during the course of malaria
infection (Fig. 7A, 7B) and was inversely correlated with IFN-g
production (Fig. 7C). Notably, the expression of PD-1 and CTLA-
4 was also inversely correlated with both T-bet and p4EBP1 ex-
pression during malaria infection (Fig. 7D, 7E). Consistent with
this, anti–PD-L1 and anti–CTLA-4 administration to block T cell
exhaustion (Fig. 7F–H) led to an increase in T-bet expression
within the overall CD4+ T cell population (Fig. 7I) and corre-
sponded with a significant increase in the level of cellular gly-
colysis and oxidative phosphorylation by CD4+ T cells on day
15 of infection (Fig. 7J). Similarly, IL-27 has been identified as
a major controller of T cell exhaustion, including during malaria
infection (25, 26, 57) (Supplemental Fig. 4A–C), and CD4+
T cells from infected WSX-12/2 mice exhibited higher T-bet
expression than CD4+ T cells from infected WT mice (on day
13 postinfection), which corresponded with significantly higher
levels of glycolysis (Supplemental Fig. 4D, 4E). Combined, these
results support the conclusion that regulatory pathways influence
the metabolic status of the effector CD4+ T cell population during
malaria infection by impacting T-bet expression and the propor-
tion of Th1 cells.
Interestingly, anti–PDL-1 and anti–CTLA-4 treatment did not
affect the level of mTORc1 activity (as inferred from p4EBP1
expression) or metabolic programming of Ag-expTh1 cells on a
cell-per-cell basis compared with Ag-expTh1 cells from con-
trol-treated–infected mice (Fig. 7K). Moreover, despite their
hyperactivated functional state (Supplemental Fig. 4B, 4C),
FIGURE 4. T cell exhaustion during PyNL infection is associated with loss of metabolically active T-bet+ cells. C57BL/6 mice were infected i.v. with
1 3 104 PyNL pRBCs. (A) Representative histogram showing T-bet MFI within Ag-expCD4+ T cells on days 5, 9, and 15 of infection compared with naive
CD4+ T cells from uninfected mice. (B) Calculated mean fluorescence intensity (MFI) (mean of the group) of T-bet in Ag-expCD4+ T cells and (C) the
proportions of Ag-expCD4+ T cells expressing T-bet on days 5, 9, and 15 of infection. (D) Correlation between T-bet and p4EBP1 levels in Ag-expCD4+
T cells on days 5 and 15 of infection. (E) Representative histograms showing the MFI and (F) calculated MFI (mean of the group) of p4EBP1, c-Myc, and
pS6 in gated splenic Ag-expT-bet+ CD4+ T cells and Ag-expT-bet2 CD4+ T cells on days 5 and 15 of infection compared with naive CD4+ T cells from
uninfected mice. Results are the mean 6 SEM of the group (n = 4) and are from one of two or three independent experiments. *p , 0.05 by one-way
ANOVA with Tukey post hoc test or Mann–Whitney U test.
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Ag-expT-bet+ Th1 cells from infected WSX-12/2 mice did not
exhibit increased expression of mTORc1-associated molecules or
nutrient transporters compared with Ag-expT-bet+ Th1 cells from
infected WT mice (Supplemental Fig. 4F). Consequently, our re-
sults indicate that regulatory pathways do not appear to directly
affect mature Th1 cell metabolism and further support the hy-
pothesis that Th1 cell activity can be modulated in vivo during
infection in the absence of differences in expression and activation
of mTORc1 and glycolysis-associated molecules within mature
Th1 cells.
Discussion
We have shown that mTOR activity and glycolytic metabolic
programming was not sustained in the Ag-expCD4+ T cell pop-
ulation throughout the course of PyNL infection, with repression
of mTOR activity and cellular glycolysis corresponding with
the temporal suppression of Ag-expCD4+ T cell functionality.
Although the phenomenon of T cell exhaustion during malaria
infection has previously been characterized (15–17), to our
knowledge, this is the first report to show that it occurs concom-
itant with loss of glycolytic metabolism and impaired mTOR
activity within the dysregulated T cells.
The downregulation of mTORc1 activity in exhausted Ag-
expCD4+ T cells during the course of malaria infection, along with
reduction in cellular glycolysis, was comparable to that observed
for exhausted Ag-specific CD8+ T cells during chronic viral in-
fections (12, 46). Therefore, these results support a model in
which effector T cell exhaustion is propagated by metabolic in-
sufficiency due to restricted uptake of nutrients (47). This could be
further enforced by the metabolic derangement, including hypo-
glycemia, that is frequently associated with blood-stage malaria
(58, 59). However, an important observation from our phenotypic
analyses was that the onset of Ag-expCD4+ T cell exhaustion was
characterized by a significant restructuring of the Ag-expCD4+
T cell compartment, in particular a dramatic decline in T-bet
expressing (Th1) cells. As the dwindling Ag-expT-bet+ Th1 cells
exhibited higher mTOR activity and nutrient transporter expres-
sion than Ag-expT-bet2 T cells throughout the course of infection,
these data are suggestive that T-bet may be a major controller of
metabolic programming and mTOR activation in Ag-expCD4+
T cells during malaria infection.
This hypothesis is supported by our observation that lack of
T-bet led to reduction in the expression of genes within effector
CD4+ T cells in pathways related to cellular metabolism and ac-
tivation of the mTOR signaling pathway, including Sgk1, which
inhibits TSC2 (50), Nedd4, which inhibits PTEN (51, 52), and
Pik3ap1, which influences AKT and Pi3K (53). Interestingly,
T-bet–mediated regulation of these genes was through a distinct
binding profile compared with genes encoding inflammatory
mediators, which are regulated by T-bet through superenhancers
FIGURE 5. T-bet activates expression of genes of the mTOR signaling pathway and signal transduction cascades that regulate mTOR function. (A)
Enrichment, shown with a 2log10 p value, of representative Gene Ontology (GO) biological process, GO molecular function, and KEGG pathways in the
set of genes significantly downregulated in T-bet2/2 versus WT CD4 T cells polarized under Th1 conditions. (B) Enrichment, shown with a2log10 p value,
of representative GO biological process, GO molecular function, and KEGG pathways in the set of genes bound by T-bet at a typical enhancer or bound by
T-bet at a superenhancer. (C) T-bet occupancy (two replicates) and RNA abundance [data from three studies (34–36)] at selected genes in the mTOR
signaling pathway in WT and T-bet2/2 cells.
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(41, 60). In addition, it has also previously been shown that T-bet
can influence the metabolic state of Ag-expCD4+ T cells indirectly
through binding and inhibiting the transcriptional repressor BCL-
6, which regulates a number of glycolysis-related genes (61).
CD8+ T cell exhaustion has also been associated with loss of
T-bet expression in other conditions (62), and T-betlowEomeshi
exhausted CD8+ T cells exhibit greater metabolic dysfunction
than T-bethiEomeslow CD8+ T cells (46, 47). Thus, whereas addi-
tional work temporally manipulating T-bet expression in effector
T cells during the course of malaria infection is required to confirm
our conclusion, it is possible that loss of T-bet corresponds with
lowered mTOR activity and glycolytic metabolism in exhausted
CD4+ T cells during chronic conditions.
The role of mTOR in influencing T-bet expression and activity in
effector CD4+ T cells during malaria infection is unclear. We have
shown, in agreement with previous studies (54, 55), that mTOR is
required to promote T-bet expression during the initial activa-
tion of T cells. However, as in a recent proteomics study from the
Cantrell group (63), mTOR activity did not appear to be critical, at
least in the short-term, to sustain T-bet protein levels or nuclear
translocation in effector Th1 cells, indicating that mTOR has
distinct temporal roles in coordinating various cellular processes
within newly activated T cells compared with mature effector
T cells. Nevertheless, directly blocking mTOR activity attenuated
IFN-g production by T cells during activation, as well as by
mature effector Th1 cells. Although this is consistent with ob-
servations that T cell effector function may be restricted when
uptake of nutrients (such as glucose) and generation of glycolytic
metabolites falls below a threshold (13, 14), our results also
showed that Ag-expT-bet+ Th1 cells exhibited a substantial loss of
effector function at the later stages of malaria despite sustaining
mTOR pathway activity. Thus, overall, our data argue that mTOR
is necessary but not sufficient for sustaining T cell effector activity
during an immune response with additional mechanisms uncou-
pled or downstream from mTOR (and potentially glycolysis) that
allow effector function to be regulated in activated Th1 cells.
FIGURE 6. mTOR does not actively control T-bet expression and is necessary but not sufficient for IFN-g production in established effector Th1 cells.
(A) Representative histograms showing T-bet mean fluorescence intensity (MFI) in splenic Ag-expCD4+ T cells obtained from days 5 and 15 of PyNL
infection incubated ex vivo with Torin or control for 4 h and compared with naive CD4+ T cells from uninfected mice (day 0). (B–F) CD4+ T cells from
C57BL/6 mice were stimulated in vitro with anti-CD3 and anti-CD28 under Th1 conditions in presence of Torin (or control) added on either day 0 or
3 poststimulation. (B and C) Representative histograms showing (B) T-bet and (C) p4EBP1 MFI in Th1-differentiated CD4+ T cells when Torin or control
was administered on day 3, with analysis on day 4 or 5, compared with naive unstimulated CD4+ T cells. (D) Representative histogram showing T-bet MFI
in Th1-differentiated CD4+ T cells when Torin or control was administered on day 0, with analysis on day 3, compared with naive unstimulated CD4+
T cells. (E) Representative dot plots showing IFN-g levels in Th1-differentiated CD4+ T cells when Torin was administered on day 0 (at priming) or on day
3 of stimulation (activated), with analysis on day 4 of stimulation. (F) The proportion of CD4+CD44+ T cells producing IFN-g when stimulated under Th1
conditions when Torin was added at priming (left graph) or on day 3 of activation (right graph), with analysis on day 4, compared with unstimulated CD4+
T cells. (G) Representative histograms showing Ki67, IFN-g, and ICOS MFI by Ag-expT-bet+ CD4+ T cells on days 5 and 15 of infection, compared with
naive CD4+ T cells from uninfected mice (day 0). (H) Representative histograms showing the MFI of metabolism-related molecules on gated Ag-expT-bet+
Th1 cells on days 5 and 15 of infection, compared naive CD4+ T cells from uninfected mice (day 0). Results are the mean 6 SEM of the group (F),
technical replicates (n = 3). The results are representative of two separate experiments with (A, G, and H) (n = 4 per group). *p , 0.05 by one-way ANOVA
with Tukey post hoc test.
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Further work is required to fully define the effects of the mTOR
pathway on T-bet activity and on the function of effector CD4+
T cells during infection.
In terms of other pathways that orchestrate CD4+ T cell ex-
haustion during malaria infection and how this is related to reg-
ulation of T-bet expression and T cell metabolism, we focused on
the roles of PD-1, CTLA-4, and IL-27. In agreement with previous
studies (18, 20, 23, 25, 26), we confirmed through combinatorial
blockade of PD-1 and CTLA-4 and through using IL-27R2/2 mice
that the pathways regulate the magnitude of the Ag-expCD4+
T cell and Ag-expT-bet+ Th1 cell responses during malaria in-
fection. Blockade of PD-1 and CTLA-4 and abrogation of IL-27R
signaling thus raised the level of T-bet within the overall CD4+
T cell population, and this directly correlated with an increase in
CD4+ T cell glycolytic metabolism during infection. However,
inhibition of these pathways did not modify the level of mTOR
activity as measured by p4EBP1 expression or the glycolytic
programming of Th1 cells. Whether these pathways influenced
mitochondrial mass and polarization [which is modified in exhausted
CD8+ T cells (46)], or other metabolic pathways, such as amino
acid metabolism, to influence Th1 effector function during in-
fection will require additional investigation.
That anti–PD-1 and anti–CTLA-4 treatment did not affect
mTOR activity in differentiated Ag-expTh1 cells during malaria
infection but did raise the level of T-bet and glycolysis in total
CD4+ T cells is consistent with a model in which combinatorial
checkpoint inhibitor treatment (re)invigorated the activation of
non-Th1 precursor exhausted CD4+ T cells. This likely facilitated
the proliferation and (re)differentiation of the precursor cells into
highly glycolytic and metabolically active Th1 cells. Indeed, in-
termediate activated CD8+ T cell stem cells, rather than terminally
differentiated and exhausted effector CD8+ T cells, have been
shown to provide the proliferative burst after checkpoint immu-
notherapy during chronic viral infection (64). Why PD-1 and
CTLA-4 may influence mTOR activity in immature or stem cells
rather than mature effector T cells may relate to their influence on
FIGURE 7. PD-1 and CTLA-4 control T-bet expression and glycolytic metabolism of total CD4+ T cells but do not influence the glycolytic metabolic
signature of mature Th1 cells during malaria infection. C57BL/6 mice were infected i.v. with 1 3 104 PyNL pRBCs and were administered i.p with anti–
PDL-1 and anti–CTLA-4 or control every second day from day 5 postinfection. (A) Representative histograms and (B) calculated mean fluorescence
intensity (MFI) (mean of the group) of PD-1 and CTLA-4 in Ag-exp CD4+ T cells during the course of infection compared with naive CD4+ T cells from
uninfected mice (day 0). (C–E) Correlation between PD-1 and CTLA-4 with (C) IFN-g, (D) T-bet, and (E) p4EBP1 in Ag-expCD4+ T cells on days 5 and 15
of infection. (F) Numbers of Ag-expT-bet+ CD4+ T cells on day 15 postinfection in anti–PDL-1– and anti–CTLA-4–treated and control-treated mice
compared with naive CD4+ T cells from uninfected mice (day 0). (G) Representative dot plot showing IFN-g and TNF levels by Ag-expT-bet+ CD4+ T cells
and (H) the numbers of IFN-g and/or TNF-positive Ag-expCD4+ T cells on day 15 postinfection. (I) Representative histogram showing T-bet MFI in splenic
CD4+ T cells from anti–PD-1– and anti–CTLA-4–treated and control-treated mice on day 15 of infection. (J) Seahorse metabolic phenotype analysis of
splenic CD4+ T cells from anti–PDL-1– and anti–CTLA-4–treated and control-treated mice on day 15 of infection. (K) Representative histograms showing
the MFI of metabolism-related molecules by splenic Ag-expT-bet+ Th1 cells from anti–PDL-1– and anti–CTLA-4–treated and control-treated mice on day
15 of infection, compared with naive CD4+ T cells from uninfected mice (day 0). Results are the mean6 SEM of the group (n = 4 or 5) and are from one of
three independent experiments. *p , 0.05 between defined groups with (H), *p, 0.05 for differences in IFN-g+ cell numbers, ∼p, 0.05 for differences in
IFN-g+TNF+ cell numbers, +p , 0.05 for differences in TNF+ cell numbers by one-way or two-way ANOVA with Tukey post hoc test.
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the CD28 pathway. CD28 promotes metabolic reprogramming and
mTOR activation during T cell activation (9, 65), and the capacity
of PD-1 and CTLA-4 to inhibit mTOR pathways and glycolysis in
CD4+ T cells during in vitro priming (28, 29) is likely linked to
antagonism of CD28 signaling (66, 67). Mature effector Th1 cells
depend less on CD28 costimulation than do naive T cells (68), and
interestingly, the rescue of exhausted CD8+ T cells following
anti–PD-1 treatment depends upon CD28 costimulation (69).
In summary, we have shown that the functional exhaustion of the
CD4+ T cell response during malaria infection occurs concomi-
tantly with alterations in mTOR activation and reduced metabolic
fitness. We have demonstrated that this decline in glycolytic
metabolism in exhausted Ag-expCD4+ T cells is related to the loss
of T-bet expression, with Ag-expTh1 cells maintaining high levels
of mTOR activity and glycolytic metabolism during infection.
How mTOR activity is regulated in Ag-expTh1 cells and its overall
importance for maintaining Th1 lineage specification and cellular
function requires additional investigation, but direct dysregulation
of mTOR activity may not be the principal reason for collapse
of the Th1 response during malaria infection. These results
have important implications for the design of immunotherapies to
reactivate Ag-specific CD4+ T cell responses during infection and
cancer.
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